Hypercard is indicated for the therapeutic treatment of specific heart conditions in cats.
Standard UK Delivery
1st Class Royal Mail delivery service. Estimated delivery by:
Guaranteed (DPD) delivery service. Estimated delivery by:
Hypercard is indicated for the therapeutic treatment of specific heart conditions in cats. Feline Primary Hypertrophic Cardiomyopathy (FPHC) is the condition in which the heart of cats is thickened and enlarged. If left untreated, FPHC can worsen and gradually progress into severe heart failure. Hypercard is often prescribed to intervene before the onset of heart failure.
The active ingredient in Hypercard acts to slow the heart and relax the cardiac muscles, thus improving circulation. By minimising resistance of constriction in this way, Hypercard enables the heart function with greater efficiency, providing oxygen and nutrition to internal organs with greater ease.
Hypercard Tablets are manufactured by Dechra and developed specifically for cats. As such, they must never be used in other animals.
Price per tablet.
To view the most up to date information about this product please read the Summary of Product Characteristics (SPC) found on the Veterinary Medicine Directorates (VMD) Product Information Database